Scientists have created a complete map showing how hundreds of possible mutations in a key cancer gene influence tumor growth ...

Chordoma is a rare tumor characterized by poor prognosis, limited therapeutic options, and a high rate of recurrence. Despite ...

Study results indicate that mutation strength may shape both tumor–immune system interactions and immunotherapy response.

Researchers in Sweden have identified an unexpected biological mechanism that could influence future cancer treatments. Scientists in Sweden have uncovered an unexpected anti-cancer effect from a ...

Researchers note that toxin appeared to concentrate its effects within tumour tissue and did not cause any harmful inflammation in mice, such as effects on body weight, functions of vital organs and ...

Scientists have created a complete map showing how hundreds of possible mutations in a key cancer gene influence tumour growth.

Scientists at the National Taiwan University Cancer Center and National Taiwan University Hospital have shed light on rare ...

Pancreatic cancer may evade the immune system not by accident but by actively switching off internal danger signals through ...

A study by Brown University Health researchers has identified a crucial factor that may help improve treatment for ...

Scientists have created a complete map showing how hundreds of possible mutations in a key cancer gene influence tumor growth. The study focused on CTNNB1, a gene that produces the protein β-catenin, ...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A Rutgers-led study in Science ...

Zanzalintinib is an investigational oral agent that inhibits tyrosine kinase receptors associated with cancer growth, including TYRO3, VEGF, MET, AXL, and MER.